Cargando…
P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429389/ http://dx.doi.org/10.1097/01.HS9.0000969548.45562.fd |
_version_ | 1785090700364218368 |
---|---|
author | Okabe, Seiichi Moriyama, Mitsuru Gotoh, Akihiko |
author_facet | Okabe, Seiichi Moriyama, Mitsuru Gotoh, Akihiko |
author_sort | Okabe, Seiichi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104293892023-08-17 P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS Okabe, Seiichi Moriyama, Mitsuru Gotoh, Akihiko Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429389/ http://dx.doi.org/10.1097/01.HS9.0000969548.45562.fd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Okabe, Seiichi Moriyama, Mitsuru Gotoh, Akihiko P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS |
title | P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS |
title_full | P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS |
title_fullStr | P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS |
title_full_unstemmed | P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS |
title_short | P661: EFFECT OF VITAMIN K2 ON COVID-19 S1 PROTEIN-INDUCED CYTOTOXICITY AGAINST HUVECS AND ON THE ACTION OF ASCIMINIB IN ABELSON-TYROSINE-KINASE-INHIBITOR-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA CELLS |
title_sort | p661: effect of vitamin k2 on covid-19 s1 protein-induced cytotoxicity against huvecs and on the action of asciminib in abelson-tyrosine-kinase-inhibitor-resistant chronic myelogenous leukemia cells |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429389/ http://dx.doi.org/10.1097/01.HS9.0000969548.45562.fd |
work_keys_str_mv | AT okabeseiichi p661effectofvitamink2oncovid19s1proteininducedcytotoxicityagainsthuvecsandontheactionofasciminibinabelsontyrosinekinaseinhibitorresistantchronicmyelogenousleukemiacells AT moriyamamitsuru p661effectofvitamink2oncovid19s1proteininducedcytotoxicityagainsthuvecsandontheactionofasciminibinabelsontyrosinekinaseinhibitorresistantchronicmyelogenousleukemiacells AT gotohakihiko p661effectofvitamink2oncovid19s1proteininducedcytotoxicityagainsthuvecsandontheactionofasciminibinabelsontyrosinekinaseinhibitorresistantchronicmyelogenousleukemiacells |